News and Trends 2 May 2019
Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients
Developed by the French biotech Genkyotex, a first-in-class treatment for the liver disease primary biliary cholangitis failed to reduce a key disease biomarker in a phase II trial, but showed…
